You have 9 free searches left this month | for more free features.

Condition

Hematologic Neoplasms (1)

Leukemia, Myeloid, Acute (1)

Myelodysplastic Syndromes (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Celgene (2)

Collaborator

Intervention

cc-90002 (2)

rituximab (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

cc-90002

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hematologic Tumors Trial in Spain, United States (CC-90002, Rituximab)

Completed

Hematologic Neoplasms

CC-90002
Rituximab

Scottsdale, Arizona
+12 more

Aug 10, 2021

Leukemia, Myeloid, Acute, MDS Trial in United States (CC-90002)

Terminated

Leukemia, Myeloid, Acute
Myelodysplastic Syndromes

CC-90002

Phoenix, Arizona
+5 more

Oct 17, 2018